Latest News
FDA Approves Exelixis' CABOMETYX® (cabozantinib) for Patients with Previously Treated Advanced Neuroendocrine Tumors
Details >FDA Approves Merck's Keytruda (pembrolizumab) with Trastuzumab, Fluoropyrimidine, and Platinum-Containing Chemo for 1st-Line Treatment of Adults With Certain Types of GEJ
Details >ACT Now! Tell Congress to Extend Telehealth Flexibilities
Without congressional action, current Medicare telehealth flexibilities will expire on March 31
Details >Report Broken Links
Have you encountered a problem with a URL (link) on this page not working or displaying an error message? Help us fix it!
